Cited by 202Advanced Glycation End Products researchProtein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site

Ishihara, Katsuya, Tsutsumi, Kae, Kawane, Shiho, Nakajima, Motowo, Kasaoka, Tatsuhiko·2003·FEBS Letters

DOI 10.1016/s0014-5793(03)00846-9

Open this paper in CoChat — free account

Abstract

The receptor for advanced glycation end‐products (RAGE)‐mediated cellular activation through the mitogen‐activated protein kinase (MAPK) cascade, activation of NF‐κB and Rho family small G‐proteins, cdc42/Rac, is implicated in the pathogenesis of inflammatory disorders and tumor growth/metastasis. However, the precise molecular mechanisms for the initiation of cell signaling by RAGE remain to be elucidated. In this study, proteins which directly bind to the cytoplasmic C‐terminus of RAGE were purified from rat lung extracts using an affinity chromatography technique and identified to be extracellular signal‐regulated protein kinase‐1 and ‐2 (ERK‐1/2). Their interactions were confirmed by immunoprecipitation of ERK‐1/2 from RAGE‐expressing HT1080 cell extracts with anti‐RAGE antibody. Furthermore, the augmentation of kinase activity of RAGE‐bound ERK upon the stimulation of cells with amphoterin was demonstrated by determining the phosphorylation level of myelin basic protein, an ERK substrate. In vitro binding studies using a series of C‐terminal deletion mutants of human RAGE revealed the importance of the membrane‐proximal cytoplasmic region of RAGE for the direct ERK–RAGE interaction. This region contained a sequence similar to the D‐domain, a ERK docking site which is conserved in some ERK substrates including MAPK‐interacting kinase‐1/2, mitogen‐ and stress‐activated protein kinase‐1, and ribosomal S6 kinase. These data suggest that ERK may play a role in RAGE signaling through direct interaction with RAGE.

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(03)00846-9

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
Donato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114002 · Cited by 1,039
Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor
Schlessinger, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00966-2 · Cited by 995

Show all 47 references

Research works printed but not linked: 1

Raabe T., 2002, Sci. STKE, 136, 1

Sorted by citations

Items 101–200 of 202

Molecular and Signaling Mechanisms of Atherosclerosis in Insulin Resistance
Schwartz, E. A., & Reaven, P. D. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.005 · Cited by 39
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions
Koerich, S., Parreira, G. M., de Almeida, D. L., Vieira, R. P., & de Oliveira, A. C. P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220922153903 · Cited by 40
Les produits de glycation avancée : un risque pour la santé humaine
Wautier, M.-P., Tessier, F. J., & Wautier, J. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2014.05.002 · Cited by 45
Internalization of the Receptor for Advanced Glycation End Products (RAGE) is Required to Mediate Intracellular Responses
Sevillano, N., Girón, M. D., Salido, M., Vargas, A. M., Vilches, J., & Salto, R. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn137 · Cited by 37
Knockdown of receptor for advanced glycation end products attenuate 17α-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells
Lata, K., & Mukherjee, T. K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.014 · Cited by 37
Atherosclerosis and restenosis: Is there a role for rage?
Nawroth, P. P., Bierhaus, A., Marrero, M. B., Yamamoto, H., & Stern, D. M. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0061-9 · Cited by 35
Systemic Inflammation Changes the Site of RAGE Expression from Endothelial Cells to Neurons in Different Brain Areas
Gasparotto, J., Ribeiro, C. T., da Rosa-Silva, H. T., Bortolin, R. C., Rabelo, T. K., Peixoto, D. O., Moreira, J. C. F., & Gelain, D. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1291-6 · Cited by 36
Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function
Hunt, W. R., Helfman, B. R., McCarty, N. A., & Hansen, J. M. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.12.011 · Cited by 35
Emerging role of mitogen‐activated protein kinases in peripheral neuropathies
Cavaletti, G., Miloso, M., Nicolini, G., Scuteri, A., & Tredici, G. (2007) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2007.00138.x · Cited by 34
RAGE plays key role in diabetic retinopathy: a review
Lu, Z., Fan, B., Li, Y., & Zhang, Y. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-023-01194-9 · Cited by 33
RAGE during infectious diseases
van Zoelen, M. A. D. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/215 · Cited by 34
High mobility group B1 up-regulates angiogenic and fibrogenic factors in human retinal pigment epithelial ARPE-19 cells
Chang, Y., Lin, C.-W., Hsieh, M.-C., Wu, H., Wu, W., Wu, W.-C., & Kao, Y.-H. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.019 · Cited by 33
Inhibition of the Receptor for Advanced Glycation End-Products (RAGE) Attenuates Neuroinflammation While Sensitizing Cortical Neurons Towards Death in Experimental Subarachnoid Hemorrhage
Li, H., Yu, J., Zhang, D.-D., Yang, Y., Huang, L.-T., Yu, Z., Chen, R.-D., Yang, H., & Hang, C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9703-y · Cited by 32
RAGE overexpression confers a metastatic phenotype to the WM115 human primary melanoma cell line
Meghnani, V., Vetter, S. W., & Leclerc, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.02.013 · Cited by 31
Crosstalk Between Calcium, Amyloid β and the Receptor for Advanced Glycation Endproducts in Alzheimer's Disease
Leclerc, E., Sturchler, E., Vetter, S. W., & Heizmann, C. W. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.2.95 · Cited by 31
Investigation of phosphoproteome in RAGE signaling
Batkulwar, K., Bansode, S. B., Patil, G. V., Godbole, R. K., Kazi, R. S., Chinnathambi, S., Shanmugam, D., & Kulkarni, M. J. (2014) · PROTEOMICS · doi:10.1002/pmic.201400169 · Cited by 30
A RAGE-antagonist peptide potentiates polymeric micelle-mediated intracellular delivery of plasmid DNA for acute lung injury gene therapy
Piao, C., Zhuang, C., Choi, M., Ha, J., & Lee, M. (2020) · Nanoscale · doi:10.1039/d0nr01367f · Cited by 29
The receptor for advanced glycation end products is a sensor for cell‐free heme
May, O., Yatime, L., Merle, N. S., Delguste, F., Howsam, M., Daugan, M. V., Paul-Constant, C., Billamboz, M., Ghinet, A., Lancel, S., et al. (2020) · FEBS Journal · doi:10.1111/febs.15667 · Cited by 31
Oligomerization Interface of RAGE Receptor Revealed by MS-Monitored Hydrogen Deuterium Exchange
Sitkiewicz, E., Tarnowski, K., Poznański, J. T., Kulma, M., & Dadlez, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076353 · Cited by 27
Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE)
Rani, S. G., Sepuru, K. M., & Yu, C. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.06.017 · Cited by 31
Role of high-mobility group box-1 protein in disruption of vascular barriers and regulation of leukocyte–endothelial interactions
Nawaz, M. I., & Mohammad, G. (2014) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2014.984309 · Cited by 26
JNK and ATF4 as two important platforms for tumor necrosis factor‐α–stimulated shedding of receptor for advanced glycation end products
Miyoshi, A., Koyama, S., Sasagawa-Monden, M., Kadoya, M., Konishi, K., Shoji, T., Inaba, M., Yamamoto, Y., & Koyama, H. (2018) · The FASEB Journal · doi:10.1096/fj.201701553rr · Cited by 25
PLC/CAMK IV–NF-κB involved in the receptor for advanced glycation end products mediated signaling pathway in human endothelial cells
You, J., Peng, W., Lin, X., Huang, Q., & Lin, J. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.036 · Cited by 25
Receptor for advanced glycation end products aggravates cognitive deficits in type 2 diabetes through binding of C‐terminal AAs 2‐5 to mitogen‐activated protein kinase kinase 3 (MKK3) and facilitation of MEKK3‐MKK3‐p38 module assembly
Zhou, X., Ying, C., Hu, B., Zhang, Y., Gan, T., Zhu, Y., Wang, N., Li, A., & Song, Y. (2022) · Aging Cell · doi:10.1111/acel.13543 · Cited by 22
DNA-based strategies for blocking HMGB1 cytokine activity: design, synthesis and preliminary in vitro / in vivo assays of DNA and DNA-like duplexes
Musumeci, D., Bucci, E. M., Roviello, G. N., Sapio, R., Valente, M., Moccia, M., Bianchi, M. E., & Pedone, C. (2011) · Molecular BioSystems · doi:10.1039/c1mb05009e · Cited by 24
Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes
Yap, F. Y. T., Kantharidis, P., Coughlan, M. T., Slattery, R. M., & Forbes, J. M. (2012) · Current Drug Targets · doi:10.2174/138945012799499758 · Cited by 22
Cell cycle related signaling in neuro2a cells proceeds via the receptor for advanced glycation end products
Schmidt, A., Kuhla, B., Bigl, K., Münch, G. W., & Arendt, T. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0770-0 · Cited by 22
Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
Bronowicka-Szydełko, A., Kotyra, Ł., Lewandowski, Ł., Gamian, A., & Kustrzeba−Wójcicka, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184084 · Cited by 21
High-mobility group box-1 protein induces mucin 8 expression through the activation of the JNK and PI3K/Akt signal pathways in human airway epithelial cells
Kim, D., Min, K., Kim, J. S., & Kwon, T. K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.131 · Cited by 21
A model of full-length RAGE in complex with S100B
Moysa, A. A., Steczkiewicz, K., Niedziałek, D., Hammerschmid, D., Zhukova, L., Sobott, F., & Dadlez, M. (2021) · Structure · doi:10.1016/j.str.2021.04.002 · Cited by 20
Expression and Characterization of Recombinant C-Terminal Biotinylated Extracellular Domain of Human Receptor for Advanced Glycation End Products (hsRAGE) in Escherichia coli
Kumano-Kuramochi, M., Xie, Q., Sakakibara, Y., Niimi, S., Sekizawa, K., Komba, S., & Machida, S. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm213 · Cited by 20
Cornuside ameliorates cognitive impairments via RAGE/TXNIP/NF-κB signaling in Aβ1-42 induced Alzheimer’s disease mice
Lian, W., Wang, Z., Zhou, F., Yuan, X., Xia, C., Wang, W., Yu, Y., Cheng, Y., Yang, H., Xu, J., et al. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10120-2 · Cited by 19
Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells THIS ARTICLE HAS BEEN RETRACTED
Guo, X., HUANG, Q., Chen, B., Wang, S., Li, Q., ZHU, Y., Hou, F. F., FU, N., Brunk, U. T., & Zhao, M. F. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_372.x · Cited by 19
Retracted
Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation
Brune, M., Müller, M., Melino, G., Bierhaus, A., Schilling, T., & Nawroth, P. P. (2012) · Oncogene · doi:10.1038/onc.2012.150 · Cited by 20
Targeting of Receptor for Advanced Glycation End Products Suppresses Cyst Growth in Polycystic Kidney Disease
Park, E. Y., Kim, B. H., Lee, E. J., Chang, E., Kim, D. W., Choi, S. Y., & Park, J. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.514166 · Cited by 19
ε-Glycation, APP and Aβ in ageing and Alzheimer disease: A hypothesis
Schmitt, H. P. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.11.016 · Cited by 19
Diaphanous-1 affects the nanoscale clustering and lateral diffusion of receptor for advanced glycation endproducts (RAGE)
Zhu, Q., & Smith, E. A. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.10.015 · Cited by 19
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration
Pehar, M., & Kinscherf, N. A. (2022) · Current Drug Targets · doi:10.2174/1389450123666220610171005 · Cited by 17
RAGE Is a Receptor for SARS-CoV-2 N Protein and Mediates N Protein–induced Acute Lung Injury
Xia, J. L., Wang, J., Ying, L., Huang, R., Zhang, K., Zhang, R., Tang, W., Xu, Q., Lai, D., Zhang, Y., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0351oc · Cited by 17
Inhalable Gene Delivery System Using a Cationic RAGE-Antagonist Peptide for Gene Delivery to Inflammatory Lung Cells
Piao, C., Kim, G., Ha, J., & Lee, M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00004 · Cited by 16
Nitroxidized-Albumin Advanced Glycation End Product and Rheumatoid Arthritis
Tarannum, A., Zarina, A. R. I. F., Khursheed, A. L. A. M., AHMAD, S., & UDDIN, M. (2019) · Archives of Rheumatology · doi:10.5606/archrheumatol.2019.7285 · Cited by 16
Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes
Tsoporis, J. N., Hatziagelaki, E. E., Gupta, S., Izhar, S., Salpeas, V., Tsiavou, A., Rigopoulos, A. G., Triantafyllis, A. S., Marshall, J. C., Parker, T. G., et al. (2020) · Molecules · doi:10.3390/molecules25225235 · Cited by 15
Role of RAGE and its ligand HMGB1 in the development of COPD
Chen, L., Sun, X., & Zhong, X. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2124087 · Cited by 15
Binding of RAGE and RIPK1 induces cognitive deficits in chronic hyperglycemia‐derived neuroinflammation
Zhou, X., Zhu, Y., Gao, L., Li, Y., Li, H., Huang, C., Liu, Y., Hu, A., Ying, C., & Song, Y. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14449 · Cited by 14
Phosphorylation of low density lipoprotein receptor-related protein 6 is involved in receptor for advanced glycation end product-mediated β-catenin stabilization in a toluene diisocyanate-induced asthma model
Xiong, J., Zhao, W., Lin, Y., Yao, L., Huang, G., Yu, C., Dong, H., Xiao, G., Zhao, H., & Cai, S. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.037 · Cited by 14
RAGE Signaling in Cell Adhesion and Inflammation
Lange-Sperandio, B., Sperandio, M., Nawroth, P. P., & Bierhaus, A. (2007) · Current Pediatric Reviews · doi:10.2174/157339607779941598 · Cited by 13
A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling
Tanuma, S., Oyama, T., Okazawa, M., Yamazaki, H., Takao, K., Sugita, Y., Amano, S., Abe, T., & Sakagami, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073426 · Cited by 11
Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
Zhou, X., Lin, N., Zhang, M., Wang, X., An, Y., Su, Q., Du, P., Li, B., & Chen, H. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00647-9 · Cited by 11
Erratum: Corrigendum: Toll-like receptor 9—dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Tian, J. Y., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S. V., Golenbock, D. T., Sirois, C. M., et al. (2007) · Nature Immunology · doi:10.1038/ni0707-780b · Cited by 11
Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.
Wang, J., Wang, H., Shi, J., & Ding, Y. (2015) · PubMed Central · Cited by 10
Trimebutine attenuates high mobility group box 1–receptor for advanced glycation end-products inflammatory signaling pathways
Nakajima, S., Ogawa, N., Yokoue, N., Tachibana, H., Tamada, K., Okazawa, M., Sato, A., Oyama, T., Abe, H., Kamiya, T., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.126 · Cited by 10
The role of microglia in the development of diabetic retinopathy and its potential clinical application
Lu, T., shang, J., Pu, S., Xu, Y., Sun, X., & Gao, X. (2025) · Human Cell · doi:10.1007/s13577-025-01226-7 · Cited by 11
Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages
Ogawa, N., Nakajima, S., Tamada, K., Yokoue, N., Tachibana, H., Okazawa, M., Oyama, T., Abe, H., Yamazaki, H., Yoshimori, A., et al. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109029 · Cited by 10
Anti-Inflammatory Functions of Protein C Require RAGE and ICAM-1 in a Stimulus-Dependent Manner
Braach, N., Buschmann, K., Pflaum, J., Hudalla, H., Koch, L., Ryschich, E., Poeschl, J., & Frommhold, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/743678 · Cited by 9
NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment
Borsi, V., Cerofolini, L., Fragai, M., & Luchinat, C. (2012) · Journal of Biomolecular NMR · doi:10.1007/s10858-012-9671-0 · Cited by 9
Rab31, a receptor of advanced glycation end products (RAGE) interacting protein, inhibits AGE induced pancreatic β-cell apoptosis through the pAKT/BCL2 pathway
Bai, R., Zhang, T., Gao, Y., Shu, T., Zhou, Y., Wang, F., Chang, X., Tang, W., Zhu, Y., & Han, X. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0594 · Cited by 8
Virtual screening of RAGE inhibitors using molecular docking
Alaparthi, M. D., Gopinath, G., Bandaru, S., Sankeshi, V., Mangalarapu, M., Nagamalla, S. S., Sudhakar, K., Rani, A. R., & Sagurthi, S. R. (2016) · Bioinformation · doi:10.6026/97320630012124 · Cited by 7
A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling
Abe, H., Okazawa, M., Oyama, T., Yamazaki, H., Yoshimori, A., Kamiya, T., Tsukimoto, M., Takao, K., Sugita, Y., Sakagami, H., et al. (2021) · Medicines · doi:10.3390/medicines8040017 · Cited by 8
HMGB1: a multifaceted mediator of cell death pathways in cardiovascular diseases
Shi, Y., Ma, Y., Wang, R., Liu, X., Duan, W., Huang, D., Wang, X., Zhao, J., & Tan, R. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02144-7 · Cited by 6
Role of receptor for advanced glycation end-products in pathogenesis of psoriasis
Soboleva, A. G., Bruskin, S. A., Николаев, А. А., Sobolev, V. V., & Mezentsev, A. (2013) · Molecular Biology · doi:10.1134/s0026893313050191 · Cited by 6
Polyol pathway and RAGE: a central metabolic and signaling axis in diabetic complications
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.52 · Cited by 5
RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications
Raj, J. A. T., John, G., Ghanekar, S., Thiruselvan, G. K., Shah, J., Ande, D., Chatterjee, A., & Goda, J. S. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150026 · Cited by 6
Adaptive evolution of the MHC class III ‐encoded receptor RAGE in primates and murine rodents
Wu, X., Wu, J., Thompson, C. W., & Li, Y. (2015) · International Journal of Immunogenetics · doi:10.1111/iji.12230 · Cited by 4
HMGB1 suppression confers neuroprotection against stroke in diabetic rats
Kim, D., Choi, I.-Y., Jang, H., & Lee, S. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0145-y · Cited by 4
A Potential Mechanism for Diabetic Wound Healing: Cutaneous Environmental Disorders
Ye, J., Xie, T., Niu, Y., Qiao, L., Tian, M., Qing, C., & Lu, S. (2016) · InTech eBooks · doi:10.5772/64052 · Cited by 4
Dynamic oligomerization of hRAGE's transmembrane and cytoplasmic domains within SDS micelles
Zamoon, J., Madhu, D., & Ahmed, I. M. M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.108 · Cited by 4
Polyphenolic Compounds Mechanisms as Inhibitors of Advanced Glycation End Products and Their Relationship to Health and Disease
Genova, V. M., Gambero, A., Campos, P. D. S. F., & Macêdo, G. A. (2022) · doi:10.1002/9781119804055.ch1 · Cited by 4
Novel biomarkers for early diagnosis and treatment strategies of diabetic retinopathy: A comprehensive review
Saravanan, K., Elavarasi, S., Revathi, G., Karuppannan, P., Ashokkumar, M., & Kumar, K. J. S. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120996 · Cited by 2
Salivary tumour necrosis factor-alpha and receptor for advanced glycation end products as prognostic and predictive markers for recurrence in oral squamous cell carcinoma – a pilot study
Brundha, M. P., Raveendran, S. R., & Rajeshkar, N. (2023) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2023.1.5 · Cited by 2
Selective Pro-Inflammatory Activation of Astrocytes by High Mobility Group Box 1 Protein Signaling
Pedrazzi, M., Melloni, E., & Sparatore, B. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384691-4.00003-1 · Cited by 2
A 3-styrylchromone converted from trimebutine 3D pharmacophore possesses dual suppressive effects on RAGE and TLR4 signaling pathways
Okazawa, M., Oyama, T., Abe, H., Yamazaki, H., Yoshimori, A., Tsukimoto, M., Yoshizawa, K., Takao, K., Sugita, Y., Kamiya, T., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.096 · Cited by 2
Endogenous Agents That Contribute to Generate or Prevent Ischemic Damage
Piazza, O., & Scarpati, G. (2012) · InTech eBooks · doi:10.5772/32745 · Cited by 1
RAGE and Its Ligands in Melanoma
Leclerc, E. (2015) · InTech eBooks · doi:10.5772/59172 · Cited by 1
The Emerging Role of RAGE in Sepsis
Weigand, M. A., Bopp, C., & Böttiger, B. W. (2007) · Springer eBooks · doi:10.1007/0-387-35096-9_2 · Cited by 1
A pathophysiologic evaluation of the receptor for advanced glycation end products (RAGE) in the lung
Englert, J. M. (2009) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
The molecular requirements for activation of specific toll-like receptor 4 signaling pathways
Esparza, G. A. (2012) · doi:10.17077/etd.ofabg36m · Cited by 1
Receptor for advanced glycation endproducts mediates allergic airway inflammation via group 2 innate lymphoid cells
Oczypok, E. A. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
The Emerging Role of RAGE in Sepsis
Weigand, M. A., Bopp, C., & Böttiger, B. W. (2006) · Yearbook of intensive care and emergency medicine · doi:10.1007/3-540-33396-7_2
Effect of glycated proteins and inhibitory compounds intervening with the AGE-RAGE pathway on macrophages
Younessi, P. (2010)
The expression of inflammatory genes in human brain endothelial cells stimulated by beta-amyloid peptides is mediated by JNK-AP1 signaling pathway
Vukic, V. (2008) · uO Research (University of Ottawa) · doi:10.20381/ruor-12230
Apoptosis and Human Diseases: Molecular Mechanisms
Sadidi, M., Sastry, A., Lastoskie, C., Vincent, A. M., Sullivan, K., & Feldman, E. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-199-4_18
Characterisation of HMGB1 in inflammation
Östberg, T. (2008) · Figshare
Role of HMGB1 in cells of the circulation
Rouhiainen, A. (2008) · Työväentutkimus Vuosikirja
DISRUPTION OF RAGE SIGNALING PREVENTS SYMPATHETIC NEURON MALFUNCTION IN HIGH GLUCOSE CONDITIONS
Chandna, A. R. (2013) · University Library - University of Saskatchewan (University of Saskatchewan)
Nucleic Acid Sensing by the Immune System: Roles For the Receptor For Advanced Glycation End Products (RAGE) and Intracellular Receptor Proteins: A Dissertation
Sirois, C. M. (2011) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/91rf-3167
Activation of receptors for advanced glycation endproducts (RAGEs) in human monocytes
Ivanova, N. (2005) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-658
RAGE- und ICAM-1-abhängige Adhäsionsmechanismen am Endothel nach myokardialer Ischämie und Reperfusion
München, L.-M.-U. (2014)
The Receptor for Advanced Glycation End-Products (RAGE) and its Ligands in Systemic Inflammation following Surgery Necessitating Cardiopulmonary Bypass
Creagh-Brown, B. C. (2011) · Spiral (Imperial College London) · doi:10.25560/7057
Expression, purification and characterisation of the recombinant soluble receptor for advanced glycosylation end products (sRAGE)
Chandler, D. J. (2014) · eSpace (Curtin University)
Development of New Antibody Based Theranostic Agents Targeting the Receptor for Advanced Glycation End-Product (Rage)
Jyoti, F. (2013) · NDSU Repository (North Dakota State University)
Involvement of glycated albumin in adipose-derived-stem cell-mediated interleukin 17 secreting T helper cell activation
Pestel, J., Robert, M., Corbin, S., Vidal, H., & Eljaafari, A. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i7.621
Place des produits de glycation avancés (AGEs) dans les complications du diabète
Vatier, C., & Fève, B. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70156-5
Binding of RAGE (AAs 362-367) and RIPK1 induces cognitive deficit in chronic hyperglycemia-derived neuroinflammationPreprint
Zhou, X., Zhu, Y., Gao, L., Li, Y., Li, H., Liu, Y., Hu, A., Ying, C., & Song, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2006841/v1
Effect of amyloid-beta 1–40 and 1–42 peptides on the lateral diffusion and signaling of receptor for advanced glycation endproducts (RAGE)
Wijesooriya, C. S., Rahman, S., & Smith, E. A. (2025) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2025.184485 · Cited by 1
RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS: EXPRESSION AND SIGNALING
Gefter, J. V. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Approche translationnelle de la voie RAGE au cours du syndrôme de détresse respiratoire aiguë : implications diagnostiques, physiopathologiques et thérapeutiques.
Jabaudon, M. (2016) · theses.fr (ABES) · doi:10.70675/e9df7955z7fe4z4cc7za51cz22b7e0c34e33
Etude de l'implication des produits de glycation avancés et de leur récepteur RAGE dans la cicatrisation de l'épithélium cornéen
Gross, C. (2018) · theses.fr (ABES) · doi:10.70675/b1be30a1z4eb0z4f63z9ef9z21fe1bfd1792
Implication de l'axe RAGE / Cathepsine S / Peptides d'élastine dans la survenue des calcifications vasculaires associées à l'Insuffisance Rénale Chronique.
Wahart, A. (2019) · doi:10.70675/6c88561fz0f5ez4ff7z9d83zc52ab129457d
RAGE Signalling in Acute Inflammatory Disorders: Therapeutic Potential of Natural Products
Wang, Q., Luo, W., Wan, Q., Li, Y., Latawiec, D., Sutton, R., Windsor, J. A., Huang, W., Szatmary, P., & Liu, T. (2026) · Biomolecules · doi:10.3390/biom16070929
RAGE phosphorylation by CK2 in human epithelial cell model: Modulation of connexin 43 expression
Coste, K., Hesse, A.-M., Marceau, G., Filhol, O., Cochet, C., Freton, C., Blanchon, L., Sapin, V., & Belville, C. (2026) · iScience · doi:10.1016/j.isci.2026.117117

Authors: Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., & Kasaoka, T.
Affiliations: Novartis (Japan) (JP)
ORCID: Nakajima, Motowo
Venue: FEBS Letters
Publisher: Wiley
Published: 2003-08-06
Volume: 550
Issue: 1-3
Pages: 107-113
ISSN: 0014-5793 (ISSN-L)
1873-3468
DOI: 10.1016/s0014-5793(03)00846-9
OpenAlex: W1965497701
Cited by: 201
References: 47
Citations by year: 2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 10 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 9 · 2015: 6 · 2014: 12 · 2013: 10 · 2012: 9
FWCI: 4.96
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: FEBS Letters (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords: receptor for advanced glycation end products, RAGE, ERK1/2, D domain, MAPK signaling, protein-protein interaction, myelin basic protein phosphorylation, amphoterin, RAGE signaling
MeSH terms: Receptor for Advanced Glycation End Products, Amino Acid Sequence, Animals, Binding Sites, Cell Extracts, Cells, Cultured, Cytoplasm, Myelin Basic Protein, Humans, Lung, Male, Phosphorylation, Receptors, Immunologic, Conserved Sequence, Rats, Wistar, Sequence Deletion, Protein Structure, Tertiary, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinases, HMGB1 Protein, Mitogen-Activated Protein Kinase 3, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks